 |
ISA’s major research contribution has been toward The Lancet Stillbirth series. These series aim to prioritize stillbirth in the context of maternal, child and newborn survival with the overall goal of bringing together epidemiology, evidence for interventions, costing estimates and policy analysis to guide decision making and promote action with measurable change by 2030.
Read more about The Lancet Stillbirth series below. Information about ISA’s other research outputs is coming soon…
|